DK0862462T3 - Kombination af en beta-receptorblokker og et opioid - Google Patents

Kombination af en beta-receptorblokker og et opioid

Info

Publication number
DK0862462T3
DK0862462T3 DK96933709T DK96933709T DK0862462T3 DK 0862462 T3 DK0862462 T3 DK 0862462T3 DK 96933709 T DK96933709 T DK 96933709T DK 96933709 T DK96933709 T DK 96933709T DK 0862462 T3 DK0862462 T3 DK 0862462T3
Authority
DK
Denmark
Prior art keywords
pct
combination
opioid
pharmaceutically acceptable
receptor blocker
Prior art date
Application number
DK96933709T
Other languages
English (en)
Inventor
Arne Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0862462T3 publication Critical patent/DK0862462T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)
DK96933709T 1995-10-06 1996-10-03 Kombination af en beta-receptorblokker og et opioid DK0862462T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination
PCT/SE1996/001248 WO1997012634A1 (en) 1995-10-06 1996-10-03 A NOVEL COMBINATION OF A β-RECEPTOR BLOCKER AND AN OPIOID

Publications (1)

Publication Number Publication Date
DK0862462T3 true DK0862462T3 (da) 2004-05-10

Family

ID=20399727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96933709T DK0862462T3 (da) 1995-10-06 1996-10-03 Kombination af en beta-receptorblokker og et opioid

Country Status (14)

Country Link
US (1) US5908847A (da)
EP (1) EP0862462B1 (da)
JP (1) JP4135977B2 (da)
AT (1) ATE259657T1 (da)
AU (1) AU706794B2 (da)
CA (1) CA2233677C (da)
DE (1) DE69631597T2 (da)
DK (1) DK0862462T3 (da)
ES (1) ES2214548T3 (da)
NO (1) NO318387B1 (da)
NZ (1) NZ319746A (da)
PT (1) PT862462E (da)
SE (1) SE9503476D0 (da)
WO (1) WO1997012634A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100306707B1 (ko) * 1998-09-07 2003-01-24 한국전기통신공사 교차이득변조형반도체광파장변환기
US7041365B2 (en) * 2003-05-12 2006-05-09 3M Innovative Properties Company Static dissipative optical construction
US8716350B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders
EP2552433A4 (en) * 2010-03-30 2013-11-06 Algynomics Inc COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities

Also Published As

Publication number Publication date
DE69631597D1 (de) 2004-03-25
CA2233677A1 (en) 1997-04-10
NZ319746A (en) 1999-11-29
SE9503476D0 (sv) 1995-10-06
EP0862462A1 (en) 1998-09-09
CA2233677C (en) 2006-08-29
PT862462E (pt) 2004-06-30
ES2214548T3 (es) 2004-09-16
ATE259657T1 (de) 2004-03-15
NO318387B1 (no) 2005-03-14
NO981222D0 (no) 1998-03-18
US5908847A (en) 1999-06-01
AU7233596A (en) 1997-04-28
JPH11513386A (ja) 1999-11-16
DE69631597T2 (de) 2004-12-16
EP0862462B1 (en) 2004-02-18
AU706794B2 (en) 1999-06-24
JP4135977B2 (ja) 2008-08-20
WO1997012634A1 (en) 1997-04-10
NO981222L (no) 1998-03-18

Similar Documents

Publication Publication Date Title
DK0744944T3 (da) Transdermale terapeutiske systemer indeholdende kønssterioder
AP9801272A0 (en) Use of an antagonist of ppar-alpha and ppr-gamma for the treatment of syndrom X.
FI974368A (fi) Kasvuhormonin vapautumista edistäviä dipeptidejä
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
DE69632146T2 (de) Einstellbares hautnetzdermatom und einrichtung zu dessen anwendung
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
IL112520A0 (en) Treatment of normal tension glaucoma
ZA200201819B (en) Preventive and therapeutic agents for eye diseases.
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
GB2274777B (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
DK0862462T3 (da) Kombination af en beta-receptorblokker og et opioid
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
PL312198A1 (en) Application of procaine in obtaining a pharmaceutical preparation of analgesic activity with minimum motorial blocking effect
DK0663832T3 (da) Anvendelse af 4'-iod-4'-deoxydoxorubicin til behandling af amyloidose
IL139144A0 (en) Mycobacterial inhibitors
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
IL143280A0 (en) Use of riluzole for treating acoustic traumas
BR9708037A (pt) Método para o tratamento de abuso de substância
SE9404438D0 (sv) New process
BG105289A (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2- (4-fluorophenyl)ethyl]-4-pip eridinemethanol for the treatment of sleep disorders
ES1030682Y (es) Equipo perfeccionado para higiene y tratamiento terapeutico.
MX9701526A (es) Terapia combinada para tratar la osteoporosis.
BG100479U (en) Medicament for the local treatment of otitis